Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Prostatic Neoplasms 2Delirium 2Thrombocytopenia 1Stomatitis 1Pleural Effusion 1Pelvic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Cyst 1Ovarian Neoplasms 1Otolaryngeal Cancer 1Metabolic Diseases 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hemostatic Disorders 1Head and Neck Neoplasms 1Emergence Delirium 1Chemotherapy-Related Cognitive Impairment 1Anemia, Aplastic 1

Interventions

Saline Solution 1Ketamine 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Otolaryngeal Cancer × Saline Solution × Clear all
NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated
71 enrolled 17 charts
Head & Neck

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡